Close

Supernus Receives FDA Notice Assigning Early April 2021 PDUFA Date for SPN-812 NDA

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/25/2024

1. META
2. CMG
3. LRCX
4. IBM
5. HCP
6. SPY
7. BSX
8. PI
9. NOW
10. ORCL


Go back to Supernus Receives FDA Notice Assigning Early April 2021 PDUFA Date for SPN-812 NDA
SUPERNUS PHARM (NASDAQ: SUPN) Delayed: 29.99 -0.27 (0.89%)
Previous Close $30.26    52 Week High $26.84 
Open $30.03    52 Week Low $9.51 
Day High $30.11    P/E N/A 
Day Low $29.78    EPS $-2.62 
Volume 18,149